Publicacións en colaboración con investigadores/as de Queen Mary University of London (10)

2024

  1. Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows

    Endocrine Reviews, Vol. 45, Núm. 5, pp. 625-654

2023

  1. Correction: RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas (Oncogene, (2021), 40, 45, (6354-6368), 10.1038/s41388-021-02009-8)

    Oncogene

2022

  1. Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases

    The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 8, pp. e3313-e3320

2021

  1. Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

    Journal of the Endocrine Society, Vol. 5, Núm. 3

  2. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas

    Oncogene, Vol. 40, Núm. 45, pp. 6354-6368

2015

  1. Ghrelin

    Molecular Metabolism, Vol. 4, Núm. 6, pp. 437-460

2008

  1. Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults

    Journal of Endocrinological Investigation, Vol. 31, Núm. 9, pp. 820-838

2007

  1. Hypopituitarism in adults and children following traumatic brain injury

    Hormone Research

2006

  1. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?

    European Journal of Endocrinology, Vol. 155, Núm. 1, pp. 109-119

  2. The importance of investigation of pituitary function in children and adolescents following traumatic brain injury

    Journal of Endocrinological Investigation, Vol. 29, Núm. 8, pp. 764-766